ReviewApolipoprotein E, Receptors, and Modulation of Alzheimer’s Disease
Section snippets
Biochemical Features of ApoE
ApoE is a glycoprotein of 299 amino acids with a molecular mass of ∼34 kDa. It transports and delivers cholesterol and other lipids in the plasma and the central nervous system (CNS) via binding to cell surface apoE receptors (Figure 1) 9, 10. The receptor-binding domain of apoE is in the N-terminal domain (residues 136–150), whereas the major lipid-binding region (residues 244–272) resides in the C-terminal domain 6, 8. The three isoforms (apoE2, apoE3, and apoE4) differ at positions 112 and
ApoE Receptors
The low-density lipoprotein receptor (LDLR) family, including LDLR, LDLR-related protein 1 (LRP1), VLDL receptor (VLDLR), and apoE receptor 2 (apoER2), are the major apoE receptors that exhibit distinct binding affinity to apoE with different isoforms and lipidation status (6). LRP1 preferentially binds to recombinant apoE or apoE aggregates, whereas LDLR and VLDLR bind to lipidated apoE particles or lipid-free apoE, respectively 6, 7, 27. In addition to the LDLR family, both lipidated and
Effects of ApoE on Brain Aβ Deposition
Using 18F-florbetapir–positron emission tomography or 11C-Pittsburgh compound B–positron emission tomography imaging, clinical studies showed that cerebral Aβ deposition is positively associated with the APOE4 genotype in cognitively normal subjects, mild cognitive impairment cases, and symptomatic AD patients 32, 33, 34. In addition, amyloid imaging positivity appears to begin earlier in cognitively intact APOE4 carriers (near 56 years of age) than APOE4 noncarriers (at 76 years of age) (35).
Mechanisms of ApoE and ApoE Receptors in Modulating Aβ Metabolism
The Aβ level in the brain represents the net balance of Aβ production and clearance (2); therefore, Aβ accumulation in AD brains may reflect overproduction, inefficient clearance, or both. Mounting evidence demonstrates that apoE and apoE receptors play important roles in these processes, which will be discussed in more detail below (Figure 2).
ApoE and ApoE Receptors in Modulating Synaptic Integrity and Plasticity
Synaptic failure, including synaptic dysfunction and synapse loss, is an early pathological feature of AD 91, 92, 93. It was reported that apoE receptors may be involved in modulating synaptic plasticity. ApoER2 and LRP1 are reported to interact with N-methyl-D-aspartate receptor subunits (94), modulate the internalization of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor, and regulate synaptic plasticity (95). LRP6 and related Wnt signaling are important for
ApoE in Tauopathy, Lipid Transport, Glucose Metabolism, Vascular Function, and Neuroinflammation
Information regarding apoE in tauopathy, lipid transport, glucose metabolism, vascular function, and neuroinflammation can be found in the Supplement.
ApoE Determines Therapeutic Responses
Several clinical trials in AD therapies demonstrated APOE genotype–dependent responses. For example, recent trials revealed that the beneficial effects of intranasal insulin treatment on cognition are modulated by APOE genotype status in AD patients 3, 79, 100. Acute treatment of short-acting intranasal insulin leads to cognitive improvement in AD patients who are APOE4 noncarriers, but not in APOE4 carriers (78). Long-acting intranasal insulin improves cognition in APOE4 AD patients but
Acknowledgments and Disclosures
This work was supported by National Institutes of Health Grant Nos. R01AG046205, R01AG035355, R01AG027924, RF1AG051504, P01NS074969, and P50AG016574 (to GB), a Cure Alzheimer’s Fund Grant (to GB), a fellowship from the BrightFocus Foundation (to C-CL), and a Pilot Grant from Mayo Clinic Alzheimer’s Disease Research Center (to NZ).
We thank Lindsey Felton for her careful reading of the manuscript.
The authors report no biomedical financial interests or potential conflicts of interest.
References (142)
- et al.
Alzheimer’s disease
Lancet
(2006) - et al.
Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype
Neurobiol Aging
(2006) - et al.
ApoE and Abeta in Alzheimer’s disease: Accidental encounters or partners?
Neuron
(2014) - et al.
Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms
J Biol Chem
(1981) - et al.
Apolipoprotein E inhibits cerebrovascular pericyte mobility through a RhoA protein-mediated pathway
J Biol Chem
(2015) - et al.
ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE
J Biol Chem
(2004) Apolipoprotein E distribution among human plasma lipoproteins: Role of the cysteine-arginine interchange at residue 112
J Lipid Res
(1990)- et al.
The role of apolipoprotein E in Alzheimer’s disease
Neuron
(2009) - et al.
Human central nervous system (CNS) apoE isoforms are increased by age, differentially altered by amyloidosis, and relative amounts reversed in the CNS compared to plasma
J Biol Chem
(2016) - et al.
Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease
J Biol Chem
(2002)
The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor
J Lipid Res
Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells
J Biol Chem
Characterization of the heparin binding sites in human apolipoprotein E
J Biol Chem
Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein
J Biol Chem
Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth
Neuroimage
Apolipoprotein E epsilon4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease
Neurobiol Aging
APOE4-specific changes in Abeta accumulation in a new transgenic mouse model of Alzheimer disease
J Biol Chem
CSF markers for incipient Alzheimer’s disease
Lancet Neurol
APP processing and synaptic function
Neuron
LRP1 modulates APP trafficking along early compartments of the secretory pathway
Neurobiol Dis
Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer’s disease
Neuron
LRP1 mediates bidirectional transcytosis of amyloid-beta across the blood-brain barrier
Neurobiol Aging
Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Abeta uptake and degradation by astrocytes
J Biol Chem
Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance
Neuron
Heparan sulfate proteoglycans mediate Abeta-induced oxidative stress and hypercontractility in cultured vascular smooth muscle cells
Mol Neurodegener
Apolipoprotein E lipoprotein particles inhibit amyloid-beta uptake through cell surface heparan sulphate proteoglycan
Mol Neurodegener
Isoform-specific binding of apolipoprotein E to beta-amyloid
J Biol Chem
The AbetaCs of Abeta-cleaving proteases
J Biol Chem
New insights into the roles of metalloproteinases in neurodegeneration and neuroprotection
Int Rev Neurobiol
Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer’s disease is associated with the apolipoprotein E-epsilon4 allele
Am J Pathol
ApoE 4 reduces the expression of Abeta degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons
Neurosci Lett
ApoE promotes the proteolytic degradation of Abeta
Neuron
The effect of amyloid associated proteins on the expression of genes involved in amyloid-beta clearance by adult human astrocytes
Exp Neurol
APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice
Mol Neurodegener
Apolipoprotein E receptor 2 interactions with the N-methyl-D-aspartate receptor
J Biol Chem
Low density lipoprotein receptor-related protein 1 (LRP1) modulates N-methyl-D-aspartate (NMDA) receptor-dependent intracellular signaling and NMDA-induced regulation of postsynaptic protein complexes
J Biol Chem
Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase C epsilon
J Biol Chem
The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics
Science
Decreased clearance of CNS beta-amyloid in Alzheimer’s disease
Science
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families
Science
Apolipoprotein E and its receptors in Alzheimer’s disease: Pathways, pathogenesis and therapy
Nat Rev Neurosci
Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy
Nat Rev Neurol
Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
Science
Apolipoprotein E: Far more than a lipid transport protein
Annu Rev Genomics Hum Genet
Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus
J Neurosci
Apolipoprotein E genotype regulates amyloid-beta cytotoxicity
J Neurosci
Genetic restoration of plasma apoE improves cognition and partially restores synaptic defects in apoE-deficient mice
J Neurosci
Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation
J Clin Invest
Plasma levels of apolipoprotein E and risk of dementia in the general population
Ann Neurol
Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism
Arterioscler Thromb Vasc Biol
Cited by (252)
Unexplored power of CRISPR-Cas9 in neuroscience, a multi-OMICs review
2024, International Journal of Biological MacromoleculesThe effect of lipid metabolism on age-associated cognitive decline: Lessons learned from model organisms and human
2023, IBRO Neuroscience ReportsPotential role of Bcl2 in lipid metabolism and synaptic dysfunction of age-related hearing loss
2023, Neurobiology of DiseaseApolipoprotein E genetic analysis in unamplified genomic DNA extracts by ligase reaction and fiber optic particle plasmon resonance biosensor
2023, Sensors and Actuators B: ChemicalIsolation of recombinant apolipoprotein E4 N-terminal domain by foam fractionation
2023, Protein Expression and Purification